Feature

Fratricide-resistant CAR T-cell therapy may have utility in acute lymphoblastic leukemia

July 5, 2018
Patients with relapsed or refractory acute lymphoblastic leukemia may benefit from a novel fratricide-resistant chimeric antigen receptor T-cell…
Feature

Insights into Huntington’s disease gene may lead to novel cancer therapies

June 30, 2018
Northwestern University researchers may have discovered why patients with Huntington’s disease have up to 80% less cancer than the general…
Feature

Stand Up To Cancer dream team strives to revolutionize myeloma treatment

June 29, 2018
Stand Up To Cancer awarded a $10 million grant to a research “dream team” that will strive to revolutionize the treatment of multiple…
Feature

Low-toxicity regimen may be best approach for mixed phenotype acute leukemia

June 28, 2018
Patients with mixed phenotype acute leukemia treated with a low-toxicity acute lymphoblastic leukemia therapy regimen achieved higher rates of…
Feature

Survivin may be target for immunotherapies in several malignancies

June 27, 2018
Survivin, an inhibitor of apoptosis protein, may be an attractive target for a variety of immunotherapeutic approaches for cancer, according to study…
Feature

CD40 may be key to activating immune response in pancreatic cancer

June 27, 2018
Researchers at University of Pennsylvania are investigating anti-CD40 antibodies in a number of combinations in pancreatic cancer and other…
Meeting News

‘Striking’ lung cancer data emerge, but uncertainty remains about upfront immuno-oncology combinations

HemOnc Today, June 25, 2018
This year’s American Association for Cancer Research Annual Meeting featured several studies that could potentially transform the care of…
Feature

Studies of immunotherapy for prostate cancer yield encouraging results

June 22, 2018
Several studies designed to investigate immunotherapies and immunotherapeutic combinations for treatment of prostate cancer have yielded encouraging…
Feature

Study of t(11;14) translocation may offer ‘valuable real-world evidence’ to advance myeloma treatment

June 22, 2018
The International Myeloma Foundation has collaborated with AbbVie on a retrospective chart review study to assess outcomes of patients with multiple…
Feature

MD Anderson Cancer Center’s colorectal cancer moon shot team designed to make fundamental changes in detection, treatment

June 21, 2018
The University of Texas MD Anderson Cancer Center’s Colorectal Cancer Moon Shot team is making significant strides in its effort to increase…